These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 24332848

  • 21. Myocardial Fibrosis in Hypertrophic Cardiomyopathy: Volumetric Assessment of Late Enhancement Provided by Cardiac Computed Tomography.
    Langer C, Schaefer P, Lutz M, Eden M, Hohnhorst M, Harders H, Faber L, Jansen O, Both M, Frey N.
    J Comput Assist Tomogr; 2015; 39(5):797-803. PubMed ID: 26125299
    [Abstract] [Full Text] [Related]

  • 22. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G, Muser D, Gianfagna P, Morocutti G, Proclemer A.
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [Abstract] [Full Text] [Related]

  • 23. Myocardial scarring on cardiovascular magnetic resonance in asymptomatic or minimally symptomatic patients with "pure" apical hypertrophic cardiomyopathy.
    Kim KH, Kim HK, Hwang IC, Lee SP, Park EA, Lee W, Kim YJ, Park JH, Sohn DW.
    J Cardiovasc Magn Reson; 2012 Jul 28; 14(1):52. PubMed ID: 22839526
    [Abstract] [Full Text] [Related]

  • 24. The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance.
    Xu HY, Yang ZG, Sun JY, Wen LY, Zhang G, Zhang S, Guo YK.
    Eur J Radiol; 2014 Apr 28; 83(4):665-72. PubMed ID: 24521610
    [Abstract] [Full Text] [Related]

  • 25. Focal ischemic myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy.
    Zhi Y, Gui FD, Xue M, Long YT, Miao W, Yi Y, Gao LC, Bing F, Pan SY.
    BMC Cardiovasc Disord; 2024 Apr 09; 24(1):203. PubMed ID: 38594610
    [Abstract] [Full Text] [Related]

  • 26. Regional Stress-Induced Ischemia in Non-fibrotic Hypertrophied Myocardium in Young HCM Patients.
    Jablonowski R, Fernlund E, Aletras AH, Engblom H, Heiberg E, Liuba P, Arheden H, Carlsson M.
    Pediatr Cardiol; 2015 Dec 09; 36(8):1662-9. PubMed ID: 26066352
    [Abstract] [Full Text] [Related]

  • 27. Distribution of Hypertrophy and Late Gadolinium Enhancement in Children and Adolescents with Hypertrophic Cardiomyopathy.
    Windram JD, Benson LN, Dragelescu A, Yoo SJ, Mertens L, Wong D, Grosse-Wortmann L.
    Congenit Heart Dis; 2015 Dec 09; 10(6):E258-67. PubMed ID: 26193909
    [Abstract] [Full Text] [Related]

  • 28. Late gadolinium enhancement on cardiac magnetic resonance represents the depolarizing and repolarizing electrically damaged foci causing malignant ventricular arrhythmia in hypertrophic cardiomyopathy.
    Sakamoto N, Kawamura Y, Sato N, Nimura A, Matsuki M, Yamauchi A, Kanno T, Tanabe Y, Takeuchi T, Natori S, Saijo Y, Aburano T, Hasebe N.
    Heart Rhythm; 2015 Jun 09; 12(6):1276-84. PubMed ID: 25684235
    [Abstract] [Full Text] [Related]

  • 29. Relationship of ECG findings to phenotypic expression in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study.
    Delcrè SD, Di Donna P, Leuzzi S, Miceli S, Bisi M, Scaglione M, Caponi D, Conte MR, Cecchi F, Olivotto I, Gaita F.
    Int J Cardiol; 2013 Aug 10; 167(3):1038-45. PubMed ID: 22464482
    [Abstract] [Full Text] [Related]

  • 30. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
    Petkow-Dimitrow P, Klimeczek P, Vliegenthart R, Pasowicz M, Miszalski-Jamka T, Oudkerk M, Podolec P, Dubiel JS, Tracz W.
    Kardiol Pol; 2009 Aug 10; 67(8A):964-9. PubMed ID: 19784900
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Endogenous contrast T1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients.
    Wang C, Zheng J, Sun J, Wang Y, Xia R, Yin Q, Chen W, Xu Z, Liao J, Zhang B, Gao F.
    J Cardiol; 2015 Dec 10; 66(6):520-6. PubMed ID: 25981868
    [Abstract] [Full Text] [Related]

  • 33. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.
    Moon JC, Mogensen J, Elliott PM, Smith GC, Elkington AG, Prasad SK, Pennell DJ, McKenna WJ.
    Heart; 2005 Aug 10; 91(8):1036-40. PubMed ID: 16020591
    [Abstract] [Full Text] [Related]

  • 34. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG, Schuurman R, Andrea B, Ripoli A, Coceani M, Chiappino S, Todiere G, Srebot V, Passino C, Aquaro GD, Emdin M, Lombardi M.
    Circ Cardiovasc Imaging; 2013 Sep 10; 6(5):790-9. PubMed ID: 23934992
    [Abstract] [Full Text] [Related]

  • 35. Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.
    Hinojar R, Fernández-Golfín C, González-Gómez A, Rincón LM, Plaza-Martin M, Casas E, García-Martín A, Fernandez-Mendez MA, Esteban A, Nacher JJJ, Zamorano JL.
    Int J Cardiol; 2017 Dec 15; 249():467-472. PubMed ID: 29121751
    [Abstract] [Full Text] [Related]

  • 36. Clinical significance of late gadolinium enhancement in patients<20 years of age with hypertrophic cardiomyopathy.
    Smith BM, Dorfman AL, Yu S, Russell MW, Agarwal PP, Mahani MG, Lu JC.
    Am J Cardiol; 2014 Apr 01; 113(7):1234-9. PubMed ID: 24513464
    [Abstract] [Full Text] [Related]

  • 37. Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy.
    Alter P, Rupp H, Adams P, Stoll F, Figiel JH, Klose KJ, Rominger MB, Maisch B.
    Eur J Heart Fail; 2011 Sep 01; 13(9):937-44. PubMed ID: 21803756
    [Abstract] [Full Text] [Related]

  • 38. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R, Varma N, Child N, Goodman B, Jabbour A, Yu CY, Gebker R, Doltra A, Kelle S, Khan S, Rogers T, Arroyo Ucar E, Cummins C, Carr-White G, Nagel E, Puntmann VO.
    Circ Cardiovasc Imaging; 2015 Dec 01; 8(12):. PubMed ID: 26659373
    [Abstract] [Full Text] [Related]

  • 39. Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.
    Rodrigues JC, Rohan S, Ghosh Dastidar A, Harries I, Lawton CB, Ratcliffe LE, Burchell AE, Hart EC, Hamilton MC, Paton JF, Nightingale AK, Manghat NE.
    Eur Radiol; 2017 Mar 01; 27(3):1125-1135. PubMed ID: 27368925
    [Abstract] [Full Text] [Related]

  • 40. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
    Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, Biller L, Lesser JR, Udelson JE, Manning WJ, Appelbaum E.
    J Am Coll Cardiol; 2009 Jul 14; 54(3):220-8. PubMed ID: 19589434
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.